-
Investment Books
-
Smart Investment
Sep
8
Pfizer to launch 2-3 generic drugs in India by Dec
Posted on: September 8, 2009 at 4:20 pm | 91 views
Pfizer intends to launch two or three generic drugs in India by December as part of its efforts to widen its portfolio and market share, reports Economic Times.
The Indian arm of Pfizer has already launched anti-hypertensive telmisartan last month.
As part of its efforts to boost growth in the generics and emerging market, Pfizer earlier in May, struck licensing agreements with two domestic generic drug makers, Aurobindo Pharma and unlisted Claris Lifesciences for some of their off-patent drugs.
Pfizer`s India unit will also outsource the manufacturing of these products.
Tags:already launched, anti-hypertensive telmisartan, Aurobindo Pharma, domestic generic drug makers, Economic Times, efforts to boost growth, emerging market, Generics, manufacturing of these products, market share, Pfizer, Pfizer earlier, struck licensing agreements, three generic drugs, unlisted Claris Lifesciences, widen its portfolio
Related Post :
-
Investment Books
-
Smart Investment
